Putnam Investments LLC Geron Corp Transaction History

Putnam Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.97 - $3.69 $10,025 - $18,778	-5,089 Reduced 3.03%	162,995 $523,000
Q1 2023 May 22, 2023	SELL	$2.14 - $3.4 $173,459 - $275,590	-81,056 Reduced 32.53%	168,084 $364,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $505,754 - $602,918	249,140 New	249,140 $602,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.